Bonnie L Bassler insider trades

Open-market stock purchases and sales by Bonnie L Bassler, Director at Royalty Pharma plc, from SEC Form 4 filings since Sep 9, 2016.

Recent trades

DateStockTradeValue
Sep 30, 2026RPRX Royalty Pharma plcBought (not open market)$37.5K
Jun 30, 2026RPRX Royalty Pharma plcBought (not open market)$37.5K
Jun 5, 2026RPRX Royalty Pharma plcBought (not open market)—
Mar 31, 2026RPRX Royalty Pharma plcBought (not open market)$37.5K
Jan 7, 2026CDTX Cidara Therapeutics, IncSold (not open market)$33.6K
Jan 7, 2026CDTX Cidara Therapeutics, IncSold (not open market)$14.8K
Jan 7, 2026CDTX Cidara Therapeutics, IncSold (not open market)$237K
Jan 7, 2026CDTX Cidara Therapeutics, IncSold (not open market)$3.3K
Jan 7, 2026CDTX Cidara Therapeutics, IncSold (not open market)$87.8K
Jan 7, 2026REGN Regeneron Pharmaceuticals, IncSold$1.2M
Jan 7, 2026CDTX Cidara Therapeutics, IncSold (not open market)$26.9K
Jan 7, 2026CDTX Cidara Therapeutics, IncSold (not open market)$365K
Jan 7, 2026REGN Regeneron Pharmaceuticals, IncBought (not open market)—
Jan 2, 2026REGN Regeneron Pharmaceuticals, IncBought (not open market)—
Jan 2, 2026REGN Regeneron Pharmaceuticals, IncBought (not open market)—
Dec 31, 2025RPRX Royalty Pharma plcBought (not open market)$37.5K
Nov 20, 2025REGN Regeneron Pharmaceuticals, IncSold$570K
Nov 20, 2025REGN Regeneron Pharmaceuticals, IncBought (not open market)—

Companies traded

  • RPRX Royalty Pharma plc: other filings, last Sep 30, 2026
  • CDTX Cidara Therapeutics, Inc: other filings, last Jan 7, 2026
  • REGN Regeneron Pharmaceuticals, Inc: 25 sales, last Jan 7, 2026
  • KLDO Kaleido Biosciences, Inc: other filings, last Jun 30, 2021

Get free alerts when Bonnie L Bassler files a new trade →